(Q37118782)

18 August 2017

1 reference

title

Review: Immune cells and mediators of inflammatory arthritis (English)

1 reference

18 August 2017

0 references

1

Georg Schett

1 reference

18 August 2017

1 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

41

1 reference

18 August 2017

3

1 reference

18 August 2017

224-229

1 reference

Evolving concepts of rheumatoid arthritis

18 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Understanding the genetic contribution to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Smoking as a trigger for inflammatory rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

The links between joint damage and disability in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Cytokines in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Analysis of the kinetics of osteoclastogenesis in arthritic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Osteoclasts are essential for TNF-alpha-mediated joint destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Bone resorption by osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

RANK is essential for osteoclast and lymph node development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Interleukin-6 modulates production of T lymphocyte–derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

Denosumab in postmenopausal women with low bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

The validity and predictive value of magnetic resonance imaging erosions in rheumatoid arthritis: Comment on the article by Goldbach-Mansky et al

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08916930701694717

10.1080/08916930701694717

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18365836